Double coil occluder

Information

  • Patent Grant
  • 7842053
  • Patent Number
    7,842,053
  • Date Filed
    Wednesday, March 30, 2005
    19 years ago
  • Date Issued
    Tuesday, November 30, 2010
    14 years ago
Abstract
An occluder that has a coil on one or both sides of a medical defect, particularly a septal defect such as a patent foramen ovale (PFO). Each coil can be formed as a tube that is hollow, with or without a closed end. The tube can be delivered over a wire. For occluding a PFO, the coils can be designed to provide a compressive force to one or both of septum primum and septum secundum.
Description
BACKGROUND

This invention relates to an occluder for closing a septal defect.


A PFO, illustrated in FIG. 1, is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Because left atrial pressure is normally higher than right atrial pressure, the flap formed by septum primum 14 and septum secundum 16 usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, which creates the possibility that blood could pass from the right atrium to the left atrium through a PFO tunnel 18 and allow blood clots to enter the systemic circulation. It is desirable to avoid this situation.


SUMMARY

Embodiments of the present invention relate to an occluder that has a coil on one or both sides of a medical defect, particularly a septal defect such as a patent foramen ovale (PFO). Each coil is preferably provided as a tube that is hollow, with or without a closed end. In some embodiments, the tube can be delivered over a wire.


In the case of use for occluding a PFO, the coils can be designed to provide a compressive force to one or both of septum primum and septum secundum of a PFO. The device can further include a tissue scaffold.


Other features and advantages will become apparent from the following detailed description and drawings.





DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view showing a patent foramen ovale (PFO).



FIGS. 2A, 2B, 3A, 3B, and 4 are various side, end, and perspective views of a device according to a first embodiment of the present invention.



FIGS. 5-8 are partial side and partial cross-sectional views showing delivery of the device of the type shown in FIG. 4.



FIGS. 9 and 10 are perspective views of additional embodiments of a device according to the present invention.



FIGS. 11-16 are perspective, plan, end, and side views of an occluder according to another embodiment of the present invention.



FIGS. 17 and 18 are perspective views of another embodiment of the present invention, which is a variation of the embodiment of FIG. 11.



FIGS. 19 and 20, and FIGS. 21 and 22 are perspective views of two additional embodiments of the present invention.



FIGS. 23-26 are partial cross-sectional, partial side views of a device of the type shown in FIG. 22 being delivered to a PFO.



FIG. 27 is a perspective view of another embodiment of the present invention showing coils with outer ends rigidly connected to a center joint.



FIG. 28 is a perspective view showing the device of FIG. 27 in a partially stretched form for loading into a catheter.



FIGS. 29-32 are partial side, partial cross-sectional views showing the delivery of the device of the type shown in FIGS. 27 and 28.





DETAILED DESCRIPTION

The present invention relates to embodiments of a septal occluder with one or two spiral coils, including a double spiral coil embodiment. The coils are preferably hollow with open or closed ends, and either or both are designed to provide a compressive force when deployed in a septal defect, such as a PFO. While the coils are preferably formed from hollow tubes that can increase the strength of the spirals over solid wires, solid wires could be used. The hollow tubes may also be easier to deliver, and can be provided over a wire. Another double spiral coil design is shown in provisional application Ser. No. 60/528,022, filed Dec. 9, 2003, and in the nonprovisional Ser. No. 11/008,539, filed Dec. 9, 2004, each of which is expressly incorporated by reference.


Referring to FIGS. 2A-4, in this embodiment, an occluder 20 has two coils, a proximal (right atrial) coil 22 and a distal (left atrial) coil 24. These coils are coupled together through a center joint 26. This center joint has a first collar 28 at an inner end of coil 22, a second collar 30 at an inner end of coil 24, and connecting rods 32 and 34 coupling collars 28 and 30. As indicated in FIGS. 2B and 3A, rods 32 and 34 are preferably in a horizontal plane in a position shown in FIG. 4 in a manufactured and non-deployed position.


Referring to FIG. 3B, when occluder 20 is in the deployed position in a PFO, coils 22 and 24 each have an upper portion in contact with septum secundum 16 and a lower portion in contact with septum primum 14. As is also indicated, rods 32 and 34 and center joint 26 can extend side-by-side in, and conform to, the geometry of the PFO tunnel between septum primum 14 and septum secundum 16.


The coils can be made from a number of different materials, including metal or nonmetal. Among nonmetals, a preferable material is a polymer, which can be a bioresorbable polymer. In this embodiment, the ends of the coils are shown as being open, but one or both of the ends could be closed, either with a solid piece or with a mesh. In this embodiment, the coils spiral outwardly from a central location.


As shown in FIG. 5, the device with coils in the form of hollow tubes can be mounted over a wire 36 that extends through an inner catheter 38. Wire 36 and catheter 38 are both in a delivery sheath 40. The device with coil 24, coil 22, and center joint 26 is in a substantially elongated and a low profile configuration, such that they fit into a sheath that is preferably 10 French or smaller, although a larger sheath could be used.


As shown in FIG. 5, sheath 40 is inserted into the left atrium. Referring to FIG. 6, sheath 40 and wire 36 are retracted, while inner catheter 38 is maintained in its current position to hold the position of coil 24. These relative movements, which can be at the same or at different rates, allow coil 24 to be released from delivery sheath 40 and into the left atrium. The coil is preferably formed from a material with good shape memory properties so that it returns to its coil form when released from sheath 40. Such a material is especially useful when the coil has a free outer end not connected to anything else.


Referring to FIGS. 7 and 8, sheath 40 and wire 36 are retracted further while inner catheter 38 is used to help maintain conduit 22 in a desired position. With such further removal, the center joint is positioned within the PFO tunnel, and coil 22 is allowed to resume its coil shape on the right atrial side of the PFO.


The device is formed with suitable materials, dimensions, and configuration so that the coils provide enough compressive force to hold together septum primum and septum secundum sufficiently to prevent clots from passing from the right atrial side to the left atrial side. As will be apparent below, while occluder 20 has a spiral that is connected to a center joint and spirals outwardly (i.e., with an increasing radius) to a free end, in other embodiments, the coil spirals inwardly from the center joint and may have an end that is connected to the center joint. In this embodiment and others, the outer surface can be roughened to produce an inflammatory effect to encourage healing. In this embodiment and others, a single coil can be used on one side of the defect, with another structure, such as an umbrella-shaped structure on the other side of the defect.



FIG. 9 is a perspective view of another embodiment of the present invention in which a device 90 is formed from a single, monolithic hollow tube shaped to form a distal coil 94, a proximal coil 92, and a connecting segment 96 that extends from the inner ends of coils 92 and 94. If desired, portions of device 90, such as at connecting segment 96, can have whiskers that can be formed by gluing short threads of the material used to make the tube or some other material, or connecting segment 96 can be partially shaved or otherwise frayed. The use of whiskers can serve as an inflammatory agent that encourages healing. While mentioned here, whiskers could be used in other embodiments.


Like the embodiment of FIG. 2a, the inner ends (i.e., smaller radius portion) of the coils are coupled to a connector or transition to a connecting segment, and the outer ends of the coils are free and are not connected to any other structure.


Referring to FIG. 10, in another embodiment of the present invention, a device 100 has a proximal coil 102 and distal coil 104. In this case, one of the coils, in this case coil 102, starts spiraling from the inside where there is a free end, and spirals out with increasing radius to an outer end of coil 102 where the coil is then curved away from the plane of the spiral and is connected to a collar 108 of a center joint 106. Distal coil 104 is shaped in a similar manner.


As is further indicated in FIG. 10, a tissue scaffold 109 can be incorporated into center joint 106. The scaffold is connected between the collars and can be bounded by the connecting rods between the collars, although it could be used at other locations instead of this location or additionally at other locations. While shown between the connecting rods, it can extend around the connecting rods and/or around other portions of the device to encapsulate them. The tissue scaffold promotes encapsulation and endothelialization, thereby further encouraging anatomical closure of septum primum and septum secundum. While shown just in FIG. 10, a tissue scaffold can be incorporated into other embodiments.


A tissue scaffold can be formed of any flexible, biocompatible material capable of promoting tissue growth, including but not limited to polyester fabrics, Teflon-based materials, such as ePTFE, polyurethanes, metallic materials, polyvinyl alcohol (PVA), extracellular matrix (ECM) or other bioengineered materials, synthetic bioresorbable polymeric scaffolds, other natural materials (e.g. collagen), or combinations of these materials. A tissue scaffold or the spiral or center joint can have drugs or biological agents to improve the defect healing process and/or to prevent clotting.


Referring to FIGS. 11-16, a device 110 according to still another embodiment can have close-ended hollow or solid spirals, and can have a free end of a coil on one or both sides of a defect locked to a center joint (FIG. 11) or unlocked (FIG. 12). By locking one or both free ends of a spiral to a center joint, the clamping force of the device can be increased relative to a device with a free end.


A center joint 116 has a latching loop 120 connected to an outer end of coil 114. From the inner end of coil 114, there is a free end 128 that can extend a short distance through loop 120. Similarly, coil 112 has an outer end attached to a latching loop 118 and an inner end that extends to a free end 130 that extends a short distance through the opening in loop 118. Free ends 128 and 130 each have a bent end that extends through latching loops 118 and 120 in a manner that they stay in the latched position. Latching loops 118 and 120 are connected together with connecting rods 122 and 124.


Additional views of this device are shown in FIGS. 13-15 and in FIG. 16 which shows the device as deployed. FIG. 15, in particular, shows how the latching loops 118 and 120 are coupled to the outer ends of the spiral, the spirals extend inwardly, and at the inner end of the spiral, a free end 128, 130 extends to the latching loop on each side. As is also shown in FIG. 16, the connecting rods 122 and 124 (not shown) have some ability to bend and conform to the geometry of the PFO tunnel, while the spirals can provide a compressive force between septum primum and septum secundum.



FIGS. 17 and 18 show an embodiment of a device 170 that is similar to that in FIGS. 11 and 12, except that rather than having free ends extending a short way through loops and held in the loops with bent ends, it has locks, such as magnetic locks, 172, 174 on the free ends. In this case, the free end has one magnetic piece and the center joint has another magnet and a conforming mechanical structure, such as a short lug and an opening for receiving the lug.


Referring to FIGS. 19 and 20, a device 190 has features of several of the embodiments above. The device has a proximal coil 192 and a distal coil 194 connected together through a center joint 196 that includes collars 198 and 199. Coil 192 is rigidly connected to a side of collar 198 from where it extends radially outwardly and then spirals inwardly until at an inner part of the spiral, it bends toward the center. At the center, there is a bent end that can extend through collar 198 to hold it in place. In this case, the interior end of the loop has a bent end for engaging the collar, but it could have the reverse form with the inner end of the spiral connected to the collar and the outer end of the spiral curved to extend through the collar. Coil 194 in this embodiment is similarly connected to the other side of the device, although the different coils can have different structures.



FIG. 20 shows device 190 of FIG. 19 with the inner ends of the coils detached from the respective collars.



FIGS. 21 and 22 show embodiments similar to those in FIGS. 19 and 20, except that the connection between the spiral and the center joint has a snap fit to hold them together. The device is shown with the center joint and spiral detached in FIG. 22. In this case, like the embodiment of FIGS. 19 and 20, the coil spirals inwardly from the outside to a lock, but it could have the reverse form of spiral.



FIGS. 23-26 show the delivery of a device of the type shown in FIGS. 21 and 22. FIG. 23 shows the device of FIG. 21 loaded into a sheath 230, and coupled to a mandrel 240 and a delivery catheter 242. As shown herein, the device has a small profile, preferably small enough to fit in a 10 F sheath. Referring to FIG. 24, sheath 230 with the loaded device is provided through the PFO tunnel and into the left atrial side. Sheath 230 is then retracted while an end cap 234 of distal coil 232 is held in place by mandrel 240 to allow a distal coil 232 and end cap 234 to be released from sheath 230. A proximal end cap is held in place with delivery catheter 242.


Referring to FIGS. 25 and 26, end cap 234 coupled to collar 235, e.g., with a snap fit, and mandrel 240 (not shown here) is withdrawn. Sheath 230 is then further retracted to release a proximal coil 236 against septum primum 14 and septum secundum 16 on the right atrial side until end cap 244 is coupled to collar 246. Delivery catheter 242 is releasably detached from end cap 244, resulting in the positioned device as shown in FIG. 26. The releasable connection between catheter 242 and end cap 244 can be with grappling hooks 250 (FIG. 25), which are generally known for use in delivering medical devices.



FIGS. 27 and 28 show another embodiment of the present invention similar to that shown in FIGS. 21 and 22, except that the device is shown with a center joint that has a rigid and generally non-separable connection to both coils. FIG. 28 shows the device of FIG. 27 in an elongated form as it would be loaded into a sheath for delivery. With further elongation, the profile of the device can be reduced to fit inside a delivery sheath as shown in FIG. 29.



FIGS. 30-32 show the release of the device of FIGS. 27 and 28 in the PFO tunnel. This delivery is generally similar to that described in conjunction with FIGS. 23-26. A device 270 with a distal coil 272, proximal coil 274, and center joint 276 is elongated as shown in FIG. 28 and loaded into a delivery sheath 278. A first delivery catheter 280 is releasably connected to a portion of coil 274 at a proximal end, and a second delivery catheter 282 is releasably connected to a portion of distal coil 272 with a connection 284. As shown in FIG. 30, sheath 278 is withdrawn while second delivery catheter 282 holds distal coil 272 in place so it can open into a coil on the left atrial side. As shown in FIGS. 31 and 32, sheath 278 is further retracted to allow right atrial coil 274 to open on the right atrial side. Coil 274 as shown is releasably held with hooks 290 to provide control over the release. Having described embodiments of the present invention, it should be understood that modifications can be made without departing from the scope of the invention.

Claims
  • 1. A device adapted to press together the septum primum and the septum secundum between the atrial chambers, the device comprising: first and second clamping spirals, each having a size suitable for use on each side of the septum, wherein each of the first and second clamping spirals has a first end at an outer edge and a free end; anda central connector for connecting the first end of the first and second clamping spirals and passing through the tunnel between the septum primum and the septum secundum,wherein at least one of the spirals includes a length of wire extending in a radial direction from an inner portion of the spiral to the outer edge of the spiral and locking the free end of the spiral to the central connector.
  • 2. The device of claim 1, wherein the spirals spiral outwardly from the central connector to the free ends.
  • 3. The device of claim 1, wherein the central connector includes at least one hollow rod extending from a central region of the first spiral to a central region of the second spiral.
  • 4. The device of claim 1, wherein the spirals and the central connector are formed from a single wire.
  • 5. The device of claim 1, wherein at least one of the spirals has a radially extending portion extending from the central connector, the at least one spiral extends inwardly back to the central connector, and the center joint is flexible.
  • 6. The device of claim 1, wherein the device is formed from a bioresorbable polymer.
  • 7. The device of claim 1, wherein the spirals each circle around more than 360°.
  • 8. The device of claim 1, wherein the central connector includes a scaffold for promoting tissue growth.
  • 9. The device of claim 1, wherein the first end of each of the first and second spirals includes a radial portion connected to the central connector.
  • 10. The device of claim 1, wherein the central connector has an opening at least one end, and the free end of at least one of the spirals is adapted to extend through the opening to form a connection.
  • 11. The device of claim 9, wherein the central connector and the second end have a snap-fit connection.
  • 12. The device of claim 1, wherein the first spiral spirals outwardly from the central connector and extends from an outermost point radially back to the central connector where the radial portion is connected to the central connector.
  • 13. The device of claim 12, wherein the radial portion is detachably connected to the central connector.
  • 14. The device of claim 12, wherein the radial portion is non-detachably connected to the central connector.
  • 15. A device adapted to be disposed in a patent foramen ovale tunnel and comprising first and second separate spirals and a connecting member together connected to the spirals with respective first and second joints, wherein each spiral has one end at an outer edge connected to one of the first and second joints, and a second end connectible to the respective first or second joint, the spirals forming closed loops when the second end is connected.
  • 16. The device of claim 15, wherein the spirals spiral outwardly from the first and second joints and have a radial portion extending inwardly from an outermost part of a spiral.
  • 17. The device of claim 15, wherein the connecting member includes two wires extending between the first and second joints.
  • 18. The device of claim 15, further comprising a membrane attached to the connecting member for promoting tissue growth.
  • 19. The device of claim 15, wherein the first and second joints have an opening for the second end to extend through.
  • 20. The device of claim 15, wherein the first and second joints have snap fit connectors for connection to the respective second ends.
  • 21. A method comprising introducing into a patent foramen ovale (PFO) the device of claim 1.
  • 22. The method of claim 21, wherein the introducing includes first providing a wire into the body, and then providing the device over the wire.
  • 23. The method of claim 22, wherein the method includes loading the device into a sheath, providing a catheter to limit movement of the device in the proximal direction, and providing the catheter, device, and sheath to the region near the PFO.
  • 24. The method of claim 23, further comprising extending the sheath and device through a PFO tunnel to a left atrium, limiting movement of the device in the proximal direction, and withdrawing the sheath in the proximal direction to release the second spiral on the left atrium side of the PFO.
  • 25. The method of claim 24, further comprising further withdrawing the sheath in the proximal direction.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority from provisional Ser. No. 60/568,526, filed May 6, 2004, which is incorporated herein by reference.

US Referenced Citations (314)
Number Name Date Kind
3344048 Kobetz et al. Sep 1967 A
3824631 Burstein et al. Jul 1974 A
3874388 King et al. Apr 1975 A
3875648 Bone Apr 1975 A
3924631 Mancusi, Jr. Dec 1975 A
4006747 Kronenthal et al. Feb 1977 A
4007743 Blake Feb 1977 A
4149327 Hammer et al. Apr 1979 A
4425908 Simon Jan 1984 A
4610674 Suzuki et al. Sep 1986 A
4626245 Weinstein Dec 1986 A
4693249 Schenck et al. Sep 1987 A
4696300 Anderson Sep 1987 A
4710181 Fuqua Dec 1987 A
4710192 Liotta et al. Dec 1987 A
4738666 Fuqua Apr 1988 A
4836204 Landymore et al. Jun 1989 A
4840623 Quackenbush Jun 1989 A
4902508 Badylak et al. Feb 1990 A
4915107 Rebuffat et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4921479 Grayzel May 1990 A
4956178 Badylak et al. Sep 1990 A
5021059 Kensey et al. Jun 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5049131 Deuss Sep 1991 A
5078736 Behl Jan 1992 A
5106913 Yamaguchi et al. Apr 1992 A
5108420 Marks Apr 1992 A
5149327 Oshiyama Sep 1992 A
5163131 Row et al. Nov 1992 A
5167363 Adkinson et al. Dec 1992 A
5167637 Okada et al. Dec 1992 A
5171259 Inoue Dec 1992 A
5176659 Mancini Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5222974 Kensey et al. Jun 1993 A
5226879 Ensminger et al. Jul 1993 A
5236440 Hlavacek Aug 1993 A
5245023 Peoples et al. Sep 1993 A
5245080 Aubard et al. Sep 1993 A
5250430 Peoples et al. Oct 1993 A
5257637 El Gazayerli Nov 1993 A
5275826 Badylak et al. Jan 1994 A
5282827 Kensey et al. Feb 1994 A
5284488 Sideris Feb 1994 A
5304184 Hathaway et al. Apr 1994 A
5312341 Turi May 1994 A
5312435 Nash et al. May 1994 A
5316262 Koebler May 1994 A
5320611 Bonutti et al. Jun 1994 A
5334217 Das Aug 1994 A
5350363 Goode et al. Sep 1994 A
5354308 Simon et al. Oct 1994 A
5364356 Hofling Nov 1994 A
5411481 Allen et al. May 1995 A
5413584 Schulze May 1995 A
5417699 Klein et al. May 1995 A
5425744 Fagan et al. Jun 1995 A
5433727 Sideris Jul 1995 A
5451235 Lock et al. Sep 1995 A
5453099 Lee et al. Sep 1995 A
5478353 Yoon Dec 1995 A
5480353 Garza, Jr. Jan 1996 A
5480424 Cox Jan 1996 A
5486193 Bourne et al. Jan 1996 A
5507811 Koike et al. Apr 1996 A
5534432 Peoples et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5562632 Davila et al. Oct 1996 A
5577299 Thompson et al. Nov 1996 A
5601571 Moss Feb 1997 A
5603703 Elsberry et al. Feb 1997 A
5618311 Gryskiewicz Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5626599 Bourne et al. May 1997 A
5634936 Linden et al. Jun 1997 A
5649950 Bourne et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5663063 Peoples et al. Sep 1997 A
5683411 Kavteladze et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5702421 Schneidt Dec 1997 A
5709707 Lock et al. Jan 1998 A
5713864 Verkaart Feb 1998 A
5717259 Schexnayder Feb 1998 A
5720754 Middleman et al. Feb 1998 A
5725552 Kotula et al. Mar 1998 A
5733294 Forber et al. Mar 1998 A
5733337 Carr, Jr. et al. Mar 1998 A
5741297 Simon Apr 1998 A
5772641 Wilson Jun 1998 A
5776162 Kleshinski Jul 1998 A
5776183 Kanesaka et al. Jul 1998 A
5797960 Stevens et al. Aug 1998 A
5800516 Fine et al. Sep 1998 A
5810884 Kim Sep 1998 A
5820594 Fontirroche et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5853420 Chevillon et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5893856 Jacob et al. Apr 1999 A
5902287 Martin May 1999 A
5902319 Daley May 1999 A
5904703 Gilson May 1999 A
5919200 Stambaugh et al. Jul 1999 A
5924424 Stevens et al. Jul 1999 A
5928250 Koike et al. Jul 1999 A
5944691 Querns et al. Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5955110 Patel et al. Sep 1999 A
5976174 Ruiz Nov 1999 A
5980505 Wilson Nov 1999 A
5989268 Pugsley, Jr. et al. Nov 1999 A
5993475 Lin et al. Nov 1999 A
5993844 Abraham et al. Nov 1999 A
5997575 Whitson et al. Dec 1999 A
6010517 Baccaro Jan 2000 A
6019753 Pagan Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6027519 Stanford Feb 2000 A
6030007 Bassily et al. Feb 2000 A
6056760 Koike et al. May 2000 A
6071998 Muller et al. Jun 2000 A
6077291 Das Jun 2000 A
6077880 Castillo et al. Jun 2000 A
6079414 Roth Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6096347 Geddes et al. Aug 2000 A
6106913 Scardino et al. Aug 2000 A
6113609 Adams Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6126686 Badylak et al. Oct 2000 A
6132438 Fleischman et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6168588 Wilson Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt et al. Jan 2001 B1
6174330 Stinson Jan 2001 B1
6183443 Kratoska et al. Feb 2001 B1
6187039 Hiles et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6190357 Ferrari et al. Feb 2001 B1
6197016 Fourkas et al. Mar 2001 B1
6199262 Martin Mar 2001 B1
6206895 Levinson Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6214029 Thill et al. Apr 2001 B1
6217590 Levinson Apr 2001 B1
6221092 Koike et al. Apr 2001 B1
6227139 Nguyen et al. May 2001 B1
6228097 Levinson et al. May 2001 B1
6231561 Frazier et al. May 2001 B1
6245080 Levinson Jun 2001 B1
6245537 Williams et al. Jun 2001 B1
6261309 Urbanski Jul 2001 B1
6265333 Dzenis et al. Jul 2001 B1
6270515 Linden et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6287317 Makower et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6299635 Frantzen Oct 2001 B1
6306150 Levinson Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312443 Stone Nov 2001 B1
6312446 Huebsch et al. Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6316262 Huisman et al. Nov 2001 B1
6319263 Levinson Nov 2001 B1
6322548 Payne et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6342064 Koike et al. Jan 2002 B1
6344048 Chin et al. Feb 2002 B1
6344049 Levinson et al. Feb 2002 B1
6346074 Roth Feb 2002 B1
6348041 Klint et al. Feb 2002 B1
6352552 Levinson et al. Mar 2002 B1
6355052 Neuss et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6358238 Sherry Mar 2002 B1
6364853 French et al. Apr 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6375625 French et al. Apr 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
6379342 Levinson Apr 2002 B1
6379368 Corcoran et al. Apr 2002 B1
6387104 Pugsley, Jr. et al. May 2002 B1
6398796 Levinson Jun 2002 B2
6402772 Amplatz et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6426145 Moroni Jul 2002 B1
6436088 Frazier et al. Aug 2002 B2
6440152 Gainor et al. Aug 2002 B1
6450987 Kramer Sep 2002 B1
6460749 Levinson et al. Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488706 Solymar et al. Dec 2002 B1
6494846 Margolis Dec 2002 B1
6494888 Laufer et al. Dec 2002 B1
6508828 Akerfeldt et al. Jan 2003 B1
6514515 Williams Feb 2003 B1
6548569 Williams et al. Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551344 Thill Apr 2003 B2
6585719 Wang Jul 2003 B2
6585755 Jackson et al. Jul 2003 B2
6596013 Yang et al. Jul 2003 B2
6599448 Ehrhard, Jr. et al. Jul 2003 B1
6610764 Martin et al. Aug 2003 B1
6623508 Shaw et al. Sep 2003 B2
6623518 Thompson et al. Sep 2003 B2
6626936 Stinson Sep 2003 B2
6629901 Huang Oct 2003 B2
6666861 Grabek Dec 2003 B1
6669722 Chen et al. Dec 2003 B2
6689589 Huisman et al. Feb 2004 B2
6712804 Roue et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6726696 Houser et al. Apr 2004 B1
6828357 Martin et al. Dec 2004 B1
6838493 Williams et al. Jan 2005 B2
6867247 Williams et al. Mar 2005 B2
6867248 Martin et al. Mar 2005 B1
6867249 Lee et al. Mar 2005 B2
6921410 Porter Jul 2005 B2
20010010481 Blanc et al. Aug 2001 A1
20010014800 Frazier et al. Aug 2001 A1
20010025132 Alferness et al. Sep 2001 A1
20010034537 Shaw et al. Oct 2001 A1
20010034567 Allen et al. Oct 2001 A1
20010037129 Thill Nov 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010044639 Levinson Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020010481 Jayaraman Jan 2002 A1
20020019648 Akerfeldt et al. Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020022860 Borillo et al. Feb 2002 A1
20020026208 Roe et al. Feb 2002 A1
20020029048 Miller Mar 2002 A1
20020032459 Horzewski et al. Mar 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020034259 Tada Mar 2002 A1
20020035374 Borillo et al. Mar 2002 A1
20020043307 Ishida et al. Apr 2002 A1
20020049457 Kaplan et al. Apr 2002 A1
20020052572 Franco et al. May 2002 A1
20020058989 Chen et al. May 2002 A1
20020077555 Schwartz Jun 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020096183 Stevens et al. Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020099390 Kaplan et al. Jul 2002 A1
20020099437 Anson et al. Jul 2002 A1
20020103492 Kaplan et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020111537 Taylor et al. Aug 2002 A1
20020111637 Kaplan et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020120323 Thompson et al. Aug 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020129819 Feldman et al. Sep 2002 A1
20020164729 Skraly et al. Nov 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183823 Pappu Dec 2002 A1
20020198563 Gainor et al. Dec 2002 A1
20030004533 Dieck et al. Jan 2003 A1
20030023266 Borillo et al. Jan 2003 A1
20030028213 Thill et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030050665 Ginn Mar 2003 A1
20030055455 Yang et al. Mar 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030059640 Marton et al. Mar 2003 A1
20030065379 Babbas et al. Apr 2003 A1
20030100920 Akin et al. May 2003 A1
20030120337 Van Tassel et al. Jun 2003 A1
20030139819 Beer et al. Jul 2003 A1
20030171774 Freudenthal et al. Sep 2003 A1
20030191495 Ryan et al. Oct 2003 A1
20030195530 Thill Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20040044361 Frazier et al. Mar 2004 A1
20040073242 Chanduszko Apr 2004 A1
20040176799 Chanduszko et al. Sep 2004 A1
20040210301 Obermiller Oct 2004 A1
20040234567 Dawson Nov 2004 A1
20050025809 Hasirci et al. Feb 2005 A1
20050043759 Chanduszko Feb 2005 A1
20050113868 Devellian et al. May 2005 A1
20050267523 Devellian et al. Dec 2005 A1
20050273135 Chanduszko et al. Dec 2005 A1
20050288786 Chanduszko Dec 2005 A1
20060122647 Callaghan et al. Jun 2006 A1
20060265004 Callaghan et al. Nov 2006 A1
20070010851 Chanduszko et al. Jan 2007 A1
20070167981 Opolski Jul 2007 A1
Foreign Referenced Citations (57)
Number Date Country
9413645 Oct 1994 DE
0362113 Apr 1990 EP
0474887 Mar 1992 EP
0 839 549 May 1998 EP
0839549 May 1998 EP
0 861 632 Sep 1998 EP
1013227 Jun 2000 EP
1046375 Oct 2000 EP
1222897 Jul 2002 EP
WO-9625179 Aug 1996 WO
WO-9631157 Oct 1996 WO
WO-9807375 Feb 1998 WO
WO 9808462 Mar 1998 WO
WO 9816174 Apr 1998 WO
WO-9829026 Jul 1998 WO
WO-9851812 Nov 1998 WO
WO-9905977 Feb 1999 WO
WO-9818864 Apr 1999 WO
WO-9918862 Apr 1999 WO
WO-9918864 Apr 1999 WO
WO-9918870 Apr 1999 WO
WO-9918871 Apr 1999 WO
WO-9930640 Jun 1999 WO
WO-0027292 May 2000 WO
WO-0044428 Aug 2000 WO
WO-0108600 Feb 2001 WO
WO-0119256 Mar 2001 WO
WO-0121247 Mar 2001 WO
WO-0128432 Apr 2001 WO
WO-0130268 May 2001 WO
WO-0149185 Jul 2001 WO
WO-0178596 Oct 2001 WO
WO-0193783 Dec 2001 WO
WO-0217809 Mar 2002 WO
WO-0224106 Mar 2002 WO
WO-03024337 Mar 2003 WO
WO-03053493 Jul 2003 WO
WO-0353493 Jul 2003 WO
WO-03059152 Jul 2003 WO
WO-03063732 Aug 2003 WO
WO-03077733 Sep 2003 WO
WO-03082076 Oct 2003 WO
WO-03103476 Dec 2003 WO
WO-2004032993 Apr 2004 WO
WO-2004037333 May 2004 WO
WO-2004043266 May 2004 WO
WO-2004043508 May 2004 WO
WO-2004052213 Jun 2004 WO
WO-2005006990 Jan 2005 WO
WO-2005018728 Mar 2005 WO
WO-2005027752 Mar 2005 WO
WO-2005074813 Aug 2005 WO
WO-2005092203 Oct 2005 WO
WO-2005110240 Nov 2005 WO
WO-2005112779 Dec 2005 WO
WO-2006036837 Apr 2006 WO
WO-2006102213 Sep 2006 WO
Related Publications (1)
Number Date Country
20050251154 A1 Nov 2005 US
Provisional Applications (1)
Number Date Country
60568526 May 2004 US